Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging
1 other identifier
interventional
15
1 country
1
Brief Summary
To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2024
CompletedFirst Submitted
Initial submission to the registry
July 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJuly 31, 2025
July 1, 2025
1.2 years
July 24, 2025
July 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in perfusion measured by tissue oxygen saturation
Change in perfusion is assessed by level of tissue oxygen saturation measured pre and post revascularization to evaluate the usefulness of SFDI in the assessment of revascularization pre and post intervention.
Pre and Post angioplasty on Day 0
Secondary Outcomes (1)
Compare SFDI measurements to Toe Pressure
Pre and Post angioplasty on Day 0
Study Arms (1)
SFDI Imaging
EXPERIMENTALSFDI Imaging performed on both ipsilateral and contralateral foot. Imaging repeated on heel and pad regions of foot.
Interventions
Eligibility Criteria
You may qualify if:
- Patients of age 21 years and above with diabetes and undergoing lower limb arterial angioplasty
- Willingness to participate in the study and undergo foot physiological assessments using SFDI
You may not qualify if:
- Mentally incompetent, younger than 21 years of age, prisoners, pregnant or breastfeeding women
- Patients unable to provide informed consent
- Any medical condition which makes the candidate an inappropriate subject for study participation, in the investigator's judgment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore General Hospital
Singapore, SG, 169856, Singapore
Related Publications (2)
Lee S, Mey L, Szymanska AF, Takhar HS, Cuccia DJ, Mazhar A, Yu K. SFDI biomarkers provide a quantitative ulcer risk metric and can be used to predict diabetic foot ulcer onset. J Diabetes Complications. 2020 Sep;34(9):107624. doi: 10.1016/j.jdiacomp.2020.107624. Epub 2020 May 19.
PMID: 32522482BACKGROUNDAmputation of limbs regarded as a last resort - Singapore General Hospital. (n.d.). Retrieved June 29, 2021, from https://www.sgh.com.sg/news/patient-care/amputation-of-limbs-regarded-as-a-last-resort
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tze Tec Chong
Singapore General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2025
First Posted
July 31, 2025
Study Start
October 2, 2024
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
All data is protected by Personal Data Protection Act.